Van Cutsem E - Search Results

1

Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013.

Papamichael D, Audisio RA, Glimelius B, de Gramont A, Glynne-Jones R, Haller D, Köhne CH, Rostoft S, Lemmens V, Mitry E, Rutten H, Sargent D, Sastre J, Seymour M, Starling N, Van Cutsem E, Aapro M. Papamichael D, et al. Among authors: van cutsem e. Ann Oncol. 2015 Mar;26(3):463-76. doi: 10.1093/annonc/mdu253. Epub 2014 Jul 11. Ann Oncol. 2015. PMID: 25015334 Free article. Review.

2

Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group.

Cunningham D, Zalcberg JR, Rath U, Oliver I, van Cutsem E, Svensson C, Seitz JF, Harper P, Kerr D, Perez-Manga G. Cunningham D, et al. Among authors: van cutsem e. Ann Oncol. 1996 Nov;7(9):961-5. doi: 10.1093/oxfordjournals.annonc.a010800. Ann Oncol. 1996. PMID: 9006748 Free article. Clinical Trial. No abstract available.

3

A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer.

Van Cutsem E, Pozzo C, Starkhammar H, Dirix L, Terzoli E, Cognetti F, Humblet Y, Garufi C, Filez L, Gruia G, Cote C, Barone C. Van Cutsem E, et al. Ann Oncol. 1998 Nov;9(11):1199-204. doi: 10.1023/a:1008478405634. Ann Oncol. 1998. PMID: 9862050 Free article. Clinical Trial.

4

Clinical advances with topoisomerase I inhibitors in gastrointestinal malignancies.

Armand JP, Cunningham D, van Cutsem E, Misset JL, Kohne CH. Armand JP, et al. Among authors: van cutsem e. Anticancer Drugs. 1999 Nov;10 Suppl 1:S5-12. doi: 10.1097/00001813-199911001-00002. Anticancer Drugs. 1999. PMID: 10630362 Review.

5

New directions in the treatment of colorectal cancer: a look to the future.

Sobrero A, Kerr D, Glimelius B, Van Cutsem E, Milano G, Pritchard DM, Rougier P, Aapro M. Sobrero A, et al. Among authors: van cutsem e. Eur J Cancer. 2000 Mar;36(5):559-66. doi: 10.1016/s0959-8049(99)00314-7. Eur J Cancer. 2000. PMID: 10738119 Review.

6

Toxicity of irinotecan in patients with colorectal cancer.

Van Cutsem E, Douillard JY, Köhne CH. Van Cutsem E, et al. N Engl J Med. 2001 Nov 1;345(18):1351-2. doi: 10.1056/NEJM200111013451818. N Engl J Med. 2001. PMID: 11794165 No abstract available.

7

Raltitrexed: current clinical status and future directions.

Van Cutsem E, Cunningham D, Maroun J, Cervantes A, Glimelius B. Van Cutsem E, et al. Ann Oncol. 2002 Apr;13(4):513-22. doi: 10.1093/annonc/mdf054. Ann Oncol. 2002. PMID: 12056700 Free article. Review.

8

Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001).

Van Cutsem E, Dicato M, Wils J, Cunningham D, Diaz-Rubio E, Glimelius B, Haller D, Johnston P, Kerr D, Koehne CH, Labianca R, Minsky B, Nordlinger B, Roth A, Rougier P, Schmoll HJ. Van Cutsem E, et al. Eur J Cancer. 2002 Jul;38(11):1429-36. doi: 10.1016/s0959-8049(02)00122-3. Eur J Cancer. 2002. PMID: 12110487

9

The role of chemotherapy in the current treatment of gastric cancer.

Van Cutsem E, Haller D, Ohtsu A. Van Cutsem E, et al. Gastric Cancer. 2002;5 Suppl 1:17-22. doi: 10.1007/s10120-002-0219-y. Gastric Cancer. 2002. PMID: 12772882 Review.

10

Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapy.

Douillard JY, Sobrero A, Carnaghi C, Comella P, Díaz-Rubio E, Santoro A, Van Cutsem E. Douillard JY, et al. Among authors: van cutsem e. Ann Oncol. 2003;14 Suppl 2:ii7-12. doi: 10.1093/annonc/mdg723. Ann Oncol. 2003. PMID: 12810451 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

732 results

Search Page